Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine effects on parathyroid hormone during arteriovenous fistula surgery under local anesthesia
ChiCTR-IPR-15006854Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Dalian Medical University
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine, midazolam and sodium chloride in secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) (3 arms), sponsored by The Second Affiliated Hospital of Dalian Medical University. Primary endpoints: Parathyroid hormone and Calcium ion. Started Jul 2015; status: recruiting.
02
Drugs
dexmedetomidinemidazolamsodium chloride
03
Conditions
secondary hyperparathyroidism (SHPT)chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR-IPR-15006854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006854.